维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Badarin"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetesmellitus显示文摘	Patil HR At Badarin FJ A1 Shami HA	2012	Am J Cardiol2012，110，：	1
2	Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension显示文摘	Al Badarin FJ Abuannadi MA Lavie CJ		0，，：	1
3	Evidence-Based Diuretic Therapy for Improving Cardiovascular Prognosis in Systemic Hypertension显示文摘	Firas J. Al Badarin Mohammad A. Abuannadi Carl J. Lavie James H. O’Keefe	2011	The American Journal of Cardiology2011，，8：	1
4	Evidence-Based Diuretic Therapy for Improving Cardiovascular Prognosis in Systemic Hypertension显示文摘	Al Badarin FJ Abuannadi MA Lavie CJ	2011	Amn J Cardiol2011，107，8：	1
5	Therapies for diabetic dyslipidae- mia显示文摘	Bell DS AI Badarin F Keefe JH Jr	2011	Diabetes Obes Metab2011，13，：	1
6	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘	Patil HR Al Badarin FJ A1 Shami HA	2012	The American journal of cardiology2012，110，6：	1
7	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mel itus显示文摘	Patil HR Al Badarin FJ Al Shami HA		0，，06：	1
8	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘	Patil HR Al Badarin F J Al Shami HA	2012	Am J Cardiol2012，110，6：	1
9	Therapies for diabetic dyslipidaemia显示文摘	Bell DS AI Badarin F O′Keefe JH Jr		0，，：	1
10	Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension显示文摘	AI Badarin FJ Abuannadi MA Lavie CJ	2011	AM J Cardiol2011，107，8：	1
11	Evidence- based diuretic therapy for improving cardiovascular prognosis in systemic hypertension 显示文摘	A1 Badarin FJ Abuannadi M A Lavie C J	2011	Am J Cardiol2011，，8：	1
12	Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy:meta-analysis of randomized,controlled trials显示文摘	From AM Al Badarin FJ McDonald FS		0，，04：	1
13	Meta analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘	Patil HR A1 Badarin FJ A1 Shami HA	2012	Am J Cardiol2012，110，6：	1
14	Iodixanol versuslow-osmolar contrast media for prevention of contrast inducednephropathy meta-analysis of randomized, controlled trials显示文摘	From AM Al Badarin FJ McDonald FS	2010	CircCardiovasc Interv2010，3，4：	1
15	Evidence based diuretic therapy for improving cardiovascular prognosis in system is hypertension显示文摘	Al Badarin FJ Abuannadi MA Lavie CJ		0，，08：	1
16	Meta-analysis of effect of dipeptidyl peptidase-4inhibitors on cardiovascular risk in type 2diabetes mellitus显示文摘	PATIL H R AL BADARIN F J AL SHAMI H A	2012	Am J Cardiol2012，110，：	1
17	Impact of ezetimibe on atherosclerosis:is the jury still out?显示文摘	AL BADARIN FJ KULLO IJ KOPECKY SL	2009	Mayo Clin Proc2009，84，4：	1
18	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘	Patil HR Al Badarin FJ Al Shami HA		0，，06：	1
19	Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus显示文摘	Patil HR A1 Badarin FJ AI Shami HA	2012	Am J Cardiol2012，110，：	1
20	Iodixanol versus low - osmolar contrast media for prevention of contrast induce,i ne- phropathy: meta - analysis of randomized, controlled trials 显示文摘	From AM A1 Badarin FJ McDonald FS	2010	Circ Cardiovasc In- terv2010，3，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示